| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.44 | 0.0006 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |